The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review
Open accessAbstract
Chronic inflammation is a common foundation for the development of many non-communicable diseases, particularly diabetes, atherosclerosis, and tumors. The activation of the axis involving Advanced Glycation End products (AGEs) and their receptor RAGE is a key promotive factor in the chronic inflammation process, influencing the pathological progression of these diseases. The accumulation of AGEs in the body results from an increase in glycation reactions and oxidative stress, especially pronounced in individuals with diabetes. By binding to RAGE, AGEs activate signaling pathways such as NF-κB, promoting the release of inflammatory factors, exacerbating cell damage and inflammation, and further advancing the formation of atherosclerotic plaques and tumor development. This review will delve into the molecular mechanisms by which the AGEs-RAGE axis activates chronic inflammation in the aforementioned diseases, as well as strategies to inhibit the AGEs-RAGE axis, aiming to slow or halt the progression of chronic inflammation and related diseases. This includes the development of AGEs inhibitors, RAGE antagonists, and interventions targeting upstream and downstream signaling pathways. Additionally, the early detection of AGEs levels and RAGE expression as biomarkers provides new avenues for the prevention and treatment of diabetes, atherosclerosis, and tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The changing landscape of atherosclerosis
Libby, P. (2021) · Nature · doi:10.1038/s41586-021-03392-8 · Cited by 2,873
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Advanced glycation endproducts—role in pathology of diabetic complications
Ahmed, N. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.09.004 · Cited by 1,455
HMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 879
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
Chronic Low Grade Inflammation in Pathogenesis of PCOS
Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680
Physical exercise in the prevention and treatment of Alzheimer's disease
De la Rosa, A., Olaso-Gonzalez, G., Arc-Chagnaud, C., Millan, F., Salvador-Pascual, A., García-Lucerga, C., Blasco-Lafarga, C., Garcia-Dominguez, E., Carretero, A., Correas, A. G., et al. (2020) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2020.01.004 · Cited by 595
Borén, J., & Williams, K. J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000330 · Cited by 524
Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06320.x · Cited by 521
Yan, S. F., Ramasamy, R., Naka, Y., & Schmidt, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000103862.26506.3d · Cited by 513
The etiology of oxidative stress in insulin resistance
Hurrle, S., & Hsu, W. H. (2017) · Biomedical Journal · doi:10.1016/j.bj.2017.06.007 · Cited by 509
Targeting RAGE Signaling in Inflammatory Disease
Hudson, B. I., & Lippman, M. E. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-041316-085215 · Cited by 502
Does accumulation of advanced glycation end products contribute to the aging phenotype?
Semba, R. D., Nicklett, E. J., & Ferrucci, L. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq074 · Cited by 490
The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient
Lorenzi, M. (2007) · Journal of Diabetes Research · doi:10.1155/2007/61038 · Cited by 472
Protein Glycation: A Firm Link to Endothelial Cell Dysfunction
Wautier, J.-L., & Schmidt, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000137876.28454.64 · Cited by 436
RAGE regulation and signaling in inflammation and beyond
Kierdorf, K., & Fritz, G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012519 · Cited by 428
Dietary Advanced Glycation End Products and Aging
Luevano-Contreras, C., & Chapman-Novakofski, K. (2010) · Nutrients · doi:10.3390/nu2121247 · Cited by 396
RAGE signaling sustains inflammation and promotes tumor development
Gebhardt, C., Riehl, A., Durchdewald, M., Németh, J., Fürstenberger, G., Müller-Decker, K., Enk, A., Arnold, B., Bierhaus, A., Nawroth, P. P., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070679 · Cited by 379
Cipollone, F., Iezzi, A., Fazia, M., Zucchelli, M., Pini, B., Cuccurullo, C., De Cesare, D., De Blasis, G., Muraro, R., Bei, R., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086014.80477.0d · Cited by 377
Dietary Advanced Glycation End Products and Their Role in Health and Disease
Uribarri, J., del Castillo, M. D., de la Maza, M. P., Filip, R., Gugliucci, A., Luevano-Contreras, C., Macías-Cervantes, M. H., Markowicz Bastos, D. H., Medrano, A., Menini, T., et al. (2015) · Advances in Nutrition · doi:10.3945/an.115.008433 · Cited by 369
FoxO integration of insulin signaling with glucose and lipid metabolism
Lee, S., & Dong, H. H. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0002 · Cited by 360
Hudson, B. I., Kalea, A. Z., del Mar Arriero, M., Harja, E., Boulanger, E., D'Agati, V., & Schmidt, A. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801465200 · Cited by 358
RAGE: a single receptor fits multiple ligands
Fritz, G. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.08.008 · Cited by 340
β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition
Jurgens, C. A., Toukatly, M. N., Fligner, C. L., Udayasankar, J., Subramanian, S. L., Zraika, S., Aston-Mourney, K., Carr, D. B., Westermark, P., Westermark, G. T., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.02.036 · Cited by 329
Inhibition of advanced glycation endproduct formation by foodstuffs
Wu, C.-H., Huang, S.-M., Lin, J.-A., & Yen, G.-C. (2011) · Food & Function · doi:10.1039/c1fo10026b · Cited by 328
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.
Wolf, Y. G., Rasmussen, L. M., & Ruoslahti, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117070 · Cited by 304
Regulation of insulin secretion: role of mitochondrial signalling
Jitrapakdee, S., Wutthisathapornchai, A., Wallace, J. C., & MacDonald, M. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1685-0 · Cited by 296
Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents
Candelaria, P. V., Leoh, L. S., Penichet, M. L., & Daniels-Wells, T. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.607692 · Cited by 268
Advanced glycation End-products (AGEs): an emerging concern for processed food industries
Sharma, C., Kaur, A., Thind, S. S., Singh, B., & Raina, S. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1851-y · Cited by 253
Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)
Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., & Shekhtman, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801622200 · Cited by 252
Insulin analogues in type 1 diabetes mellitus: Getting better all the time
Mathieu, C., Gillard, P., & Benhalima, K. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.39 · Cited by 248
The Metabolic Syndrome and Inflammation
Sutherland, J. P., McKinley, B., & Eckel, R. H. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.82 · Cited by 243
The receptor RAGE: Bridging inflammation and cancer
Riehl, A., Németh, J., Angel, P., & Hess, J. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-12 · Cited by 231
Insulin structure and function
Mayer, J. P., Zhang, F., & DiMarchi, R. D. (2007) · Peptide Science · doi:10.1002/bip.20734 · Cited by 230
Van Nguyen, C. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600144 · Cited by 219
Advanced Glycation End Product Recognition by the Receptor for AGEs
Xue, J., Rai, V., Singer, D., Chabierski, S., Xie, J., Reverdatto, S., Burz, D. S., Schmidt, A. M., Hoffmann, R., & Shekhtman, A. (2011) · Structure · doi:10.1016/j.str.2011.02.013 · Cited by 217
Nandipati, K. C., Subramanian, S., & Agrawal, D. K. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2878-8 · Cited by 208
Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases
Cepas, V., Collino, M., Mayo, J. C., & Sainz, R. M. (2020) · Antioxidants · doi:10.3390/antiox9020142 · Cited by 202
Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
Tanase, D. M., Gosav, E. M., Anton, M. I., Floria, M., Seritean Isac, P. N., Hurjui, L. L., Tarniceriu, C. C., Costea, C. F., Ciocoiu, M., & Rezus, C. (2022) · Biomolecules · doi:10.3390/biom12091227 · Cited by 198
The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction
Sergi, D., Boulestin, H., Campbell, F. M., & Williams, L. M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900934 · Cited by 194
Dattilo, B. M., Fritz, G., Leclerc, E., Vander Kooi, C. W., Heizmann, C. W., & Chazin, W. J. (2007) · Biochemistry · doi:10.1021/bi7003735 · Cited by 192
Yang, Z., Makita, Z., Horii, Y., Brunelle, S., Cerami, A., Sehajpal, P., Suthanthiran, M., & Vlassara, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.515 · Cited by 192
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Ahmad, S., Khan, H., Siddiqui, Z., Khan, M. Y., Rehman, S., Shahab, U., Godovikova, T., Silnikov, V., & Moinuddin (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.001 · Cited by 192
RAGE: a novel biological and genetic marker for vascular disease
Kalea, A. Z., Schmidt, A. M., & Hudson, B. I. (2009) · Clinical Science · doi:10.1042/cs20080494 · Cited by 183
Diabetes Mellitus and Cardiovascular Disease: Emerging Therapeutic Approaches
Schmidt, A. M. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.310961 · Cited by 183
Scavenger receptors for oxidized and glycated proteins
Horiuchi, S., Sakamoto, Y., & Sakai, M. (2003) · Amino Acids · doi:10.1007/s00726-003-0029-5 · Cited by 175
An update on advanced glycation endproducts and atherosclerosis
Turco, S. D., & Basta, G. (2012) · BioFactors · doi:10.1002/biof.1018 · Cited by 170
Ozaki, K.-I., Awazu, M., Tamiya, M., Iwasaki, Y., Harada, A., Kugisaki, S., Tanimura, S., & Kohno, M. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00445.2015 · Cited by 165
Cai, W., He, J. C., Zhu, L., Lu, C., & Vlassara, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600362103 · Cited by 163
Fueling inflammation at tumor microenvironment: the role of multiligand/rage axis
Armando Rojas, R., Figueroa, H., & Morales, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp322 · Cited by 158
The β-cell assassin: IAPP cytotoxicity
Raleigh, D. P., Zhang, X., Hastoy, B., & Clark, A. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0105 · Cited by 150
AGE-RAGE synergy influences programmed cell death signaling to promote cancer
Waghela, B. N., Vaidya, F. U., Ranjan, K., Chhipa, A. S., Tiwari, B. S., & Pathak, C. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03928-y · Cited by 147
Duan, Z., Wang, Y., Lü, Z., Tian, L., Xia, Z.-Q., Wang, K., Chen, T., Wang, R., Feng, Z.-Y., Shi, G., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154658 · Cited by 137
Site-Specific Blockade of RAGE-VdPrevents Amyloid-β Oligomer Neurotoxicity
Sturchler, E., Galichet, A., Weibel, M., Leclerc, E., & Heizmann, C. W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4878-07.2008 · Cited by 136
Yamagishi, S., Fukami, K., & Matsui, T. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0176-5 · Cited by 135
Erusalimsky, J. D. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101958 · Cited by 131
Jud, P., & Sourij, H. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.11.016 · Cited by 129
RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration
Gąsiorowski, K., Brokos, B., Echeverría, V., Barreto, G. E., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0419-4 · Cited by 127
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
Chiappalupi, S., Sorci, G., Vukašinović, A., Salvadori, L., Sagheddu, R., Coletti, D., Renga, G., Romani, L. R., Donato, R., & Riuzzi, F. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12561 · Cited by 127
Fotheringham, A. K., Gallo, L. A., Borg, D. J., & Forbes, J. M. (2022) · Nutrients · doi:10.3390/nu14132675 · Cited by 127
Coughlan, M. T., Thallas-Bonke, V., Pete, J., Long, D. M., Gasser, A., Tong, D. C. K., Arnstein, M., Thorpe, S. R., Cooper, M. E., & Forbes, J. M. (2007) · Endocrinology · doi:10.1210/en.2006-1300 · Cited by 124
Kong, T., Liu, M., Ji, B., Bai, B., Cheng, B., & Wang, C. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01038 · Cited by 116
AGEs and chronic subclinical inflammation in diabetes: disorders of immune system
Hu, H., Jiang, H., Ren, H., Hu, X., Wang, X., & Han, C. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2560 · Cited by 115
Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts
Brown, R. D., Jones, G. M., Laird, R. E., Hudson, P., & Long, C. S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.003 · Cited by 113
Gabryelska, A., Karuga, F. F., Szmyd, B. M., & Białasiewicz, P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01035 · Cited by 113
Litwinoff, E., del Pozo, C. H., Ramasamy, R., & Schmidt, A. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.148 · Cited by 112
The discovery of insulin revisited: lessons for the modern era
Lewis, G. F., & Brubaker, P. L. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142239 · Cited by 112
Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors
Kim, H. J., Jeong, M. S., & Jang, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136904 · Cited by 110
Advanced Glycation End Products and Nephrotoxicity of High-Protein Diets
Uribarri, J., & Tuttle, K. R. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01270406 · Cited by 108
Morroniside attenuates high glucose–induced BMSC dysfunction by regulating the Glo1/AGE/RAGE axis
Sun, Y., Zhu, Y., Liu, X., Chai, Y., & Xu, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12866 · Cited by 106
Sidarala, V., & Kowluru, A. (2016) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214810666161020154905 · Cited by 105
AGE–RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease
Prasad, K. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03553-4 · Cited by 101
Bram, Y., Frydman‐Marom, A., Yanai, I., Gilead, S., Shaltiel‐Karyo, R., Amdursky, N., & Gazit, E. (2014) · Scientific Reports · doi:10.1038/srep04267 · Cited by 98
Oxidative Stress-Mediated Induction of MMP-1 and MMP-3 in Human RPE Cells
Priglinger, C., Kreutzer, T. C., Obholzer, K., Wolf, A., Mempel, M., Kernt, M., Kampik, A., & Priglinger, S. G. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3193 · Cited by 96
Advanced glycation endproducts: A biomarker for age as an outcome predictor after cardiac surgery?
Simm, A., Wagner, J., Gursinsky, T., Naß, N., Friedrich, I., Schinzel, R., Czeslick, E. G., Silber, R.-E., & Scheubel, R. J. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.03.006 · Cited by 91
Jukema, R., Ahmed, T. A.-H. N., & Tardif, J. (2019) · BMC Medicine · doi:10.1186/s12916-019-1433-3 · Cited by 86
RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity
Abedini, A., Cao, P., Plesner, A., Zhang, J., He, M., Derk, J., Patil, S. A., Rosario, R., Lonier, J., Song, F., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci85210 · Cited by 84
Alagebrium and Complications of Diabetes Mellitus
Toprak, Ç., & Yiğitaslan, S. (2019) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2019.18434 · Cited by 75
Chen, Y., Chen, J., Jiang, M., Fu, Y., Zhu, Y., Jiao, N., Liu, L., Du, Q., Wu, H., Xu, H., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117653 · Cited by 73
Park, W., Gray, J. M., Holewinski, R. J., Andrésson, Þ., So, J. Y., Carmona‐Rivera, C., Hollander, M. C., Yang, H. H., Lee, M. P., Kaplan, M. J., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00524-z · Cited by 65
Xu, L., Wang, Y., Li, P., & Feng, B. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0334-0 · Cited by 64
Palanissami, G., & Paul, S. F. D. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00170 · Cited by 56
Yuan, Y., Zhao, L., Chen, Y., Moorhead, J. F., Varghese, Z., Powis, S. H., Minogue, S., Sun, Z., & Ruan, X. Z. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00646.2010 · Cited by 50
Stat3 activation induces insulin resistance via a muscle-specific E3 ubiquitin ligase Fbxo40
Zhang, L., Chen, Z., Wang, Y., Tweardy, D. J., & Mitch, W. E. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00480.2019 · Cited by 49
Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging
Portero‐Otín, M., de la Maza, M. P., & Uribarri, J. (2023) · Cells · doi:10.3390/cells12131684 · Cited by 47
Effects of Toxic AGEs (TAGE) on Human Health
Takeuchi, M., Sakai, A., Takata, T., Takino, J.-I., & Koriyama, Y. (2022) · Cells · doi:10.3390/cells11142178 · Cited by 46
Inciting inflammation: the RAGE about tumor promotion
Dougan, M. L., & Dranoff, G. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080136 · Cited by 44
Atherosclerosis and the Hypercholesterolemic AGE–RAGE Axis
Qureshi, M., Prasad, K., Pearce, C., & McNair, E. (2016) · International Journal of Angiology · doi:10.1055/s-0035-1570754 · Cited by 44
Revisiting amino acids and peptides as anti-glycation agents
Chilukuri, H., Kulkarni, M. J., & Fernandes, M. (2018) · MedChemComm · doi:10.1039/c7md00514h · Cited by 38
Protective mechanism of fruit vinegar polyphenols against AGEs-induced Caco-2 cell damage
Wu, Q., Kong, Y., Liang, Y., Niu, M., Feng, N., Zhang, C., Qi, Y., Guo, Z., Xiao, J., Zhou, M., et al. (2023) · Food Chemistry X · doi:10.1016/j.fochx.2023.100736 · Cited by 35
Self-citationEffect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients
Motawi, T. K., Abou-Seif, M. A., Bader, A., & Mahmoud, M. O. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-32 · Cited by 34
Herrera, J. J., Louzon, S., Pifer, K., Leander, D. C., Merrihew, G. E., Park, J. H., Szczesniak, K., Whitson, J. D., Wilkinson, J. E., Fiehn, O., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137474 · Cited by 34
Role of the DNAJ/HSP40 family in the pathogenesis of insulin resistance and type 2 diabetes
Diané, A., Abunada, H. H., Khattab, N., Moin, A. S. M., Butler, A. E., & Dehbi, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101313 · Cited by 30
Tesařová, P., Kalousová, M., Zima, T., & Tesař, V. (2016) · Biomedical Papers · doi:10.5507/bp.2016.003 · Cited by 29
Arivazhagan, L., López‐Díez, R., Shekhtman, A. G., Ramasamy, R., & Schmidt, A. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.937071 · Cited by 28
Potential of glycative stress targeting for cancer prevention
Piperi, C., Adamopoulos, C., & Papavassiliou, A. G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.020 · Cited by 27
Kovacic, P., & Somanathan, R. (2011) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2011.607171 · Cited by 26
Choi, J., Oh, S., Son, M., & Byun, K. (2019) · Marine Drugs · doi:10.3390/md17110612 · Cited by 26
Chang, M., Zhang, B., Tian, Y., Hu, M., Zhang, G., Di, Z., Wang, X., Liu, Z., Gu, N., & Liu, Y. (2016) · Inflammation · doi:10.1007/s10753-016-0493-1 · Cited by 24
Santolla, M. F., Talia, M., Cirillo, F., Scordamaglia, D., Rosis, S. D., Spinelli, A., Miglietta, A., Nardo, B., Filippelli, G., Francesco, E. M. D., et al. (2022) · Cells · doi:10.3390/cells11152402 · Cited by 24
He, H., Sun, Y., Zhang, S., Zhang, H., Su, W., Guo, Z., Zhang, Y. L., Wen, J.-J., Li, X., Hu, J., et al. (2022) · eFood · doi:10.1002/efd2.1 · Cited by 23
Self-citationShirakihara, T., Yamaguchi, H., Kondo, T., Yashiro, M., & Sakai, R. (2022) · Oncogene · doi:10.1038/s41388-022-02270-5 · Cited by 22
Miao, L., Cheong, M. S., Zhou, C., Farag, M. A. F., Cheang, W. S., & Xiao, J. (2022) · Food Frontiers · doi:10.1002/fft2.192 · Cited by 22
Francisqueti‐Ferron, F. V., Ferron, A. J. T., Altomare, A., Garcia, J. L., Moreto, F., Ferreira, A. L. A., Minatel, I. O., Aldini, G., & Corrêa, C. R. (2021) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2021-0002 · Cited by 19
Repurposing alagebrium for diabetic foot ulcer healing: Impact on AGEs/NFκB/NOX1 signaling
Harb, A., Elbatreek, M. H., Elshahat, A., El-Akabawy, N., Barakat, W., & Elkomy, N. M. I. M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176083 · Cited by 16
Huang, C., Xu, T., Li, Y., & Ren, J. (2022) · Food Frontiers · doi:10.1002/fft2.162 · Cited by 15
Jaipal, N., Ram, H., Charan, J., Dixit, A., Singh, G., Singh, B. P., Kumar, A., & Panwar, A. (2022) · eFood · doi:10.1002/efd2.42 · Cited by 15
Wang, Z., Yao, H., & Sun, Z. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i3.222 · Cited by 14
Shen, W., Elahi, M., Wang, B., Zhan, M., Yang, P., & Yang, P. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215687 · Cited by 10
Cited by
Zhao, F., Wang, H., Li, S., Yun, H., & Su, W. (2026) · PeerJ · doi:10.7717/peerj.20710 · Cited by 6
Metadata
- Authors
- Zhou, M., Zhang, Y., Shi, L., Li, L., Zhang, D., Gong, Z., & Wu, Q.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2024-08
- Volume
- 206
- Pages
- 107282
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W4399915526
- Cited by
- 253
- References
- 110
- FWCI
- 59.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.